SCiFi Foods
The business, the turning points, and the decisions behind them.
01 / WHAT IT BUILT
What the company did
SCiFi Foods was a San Leandro, California cultivated-meat startup founded in 2019 as Artemys Foods by Joshua March and Dr. Jessica Krieger (Krieger left in 2020; Dr. Kasia Gora joined as co-founder and CTO in 2020), rebranding to SCiFi Foods in 2022. It took a pragmatic hybrid approach: rather than 100% cultured steaks, it made the SCiFi Burger from a blend of 90% plant protein and 10% cultivated beef, arguing that 10% inclusion was commercially viable with existing technology. It raised about $40 million from investors including Andreessen Horowitz, Coldplay, Valor Siren Ventures, BoxGroup, Entree Capital and Prelude Ventures, and opened a 16,000-square-foot pilot plant where it ran a commercial-scale production in a 500-liter bioreactor.
02 / SCiFi Foods FAILURE REASONS
Failure factors supported by the current evidence
SCiFi Foods reached the end of its cash runway and could not raise the capital needed to commercialize its cultivated-meat burger in the prevailing funding environment.
The company could not raise the capital required to commercialize its product.
The company reached the end of its cash runway.
03 / EVENT HISTORY
Events in the structured record
- Operations ended
SCiFi Foods announced its closure in June 2024 and hired a firm to sell its intellectual property and assets.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / AFTERMATH
Lessons
SCiFi's pragmatic hybrid strategy — 10% cultivated meat in a plant burger — was arguably the most commercially grounded thesis in cultivated meat, yet still could not survive the sector's funding freeze. The silver lining is institutional: SCiFi's open release of cell lines and patents through GFI and Tufts turned a private failure into a public asset, saving academia and industry millions in R&D.